arXiv subjects

Mohammad Moshahid Khan

Publications and source records attributed to Mohammad Moshahid Khan.

5 recordsLinked to original sources

arXiv2025

Alterations of brain tissue structural complexity and disorder in Alzheimer's disease (AD): Fractal, multifractal, fractal transformation, and disorder strength analyses

Alzheimer's disease (AD) is characterized by progressive microstructural deterioration in brain tissue, yet conventional imaging and histopathology often lack the sensitivity needed to detect subtle early-stage changes. Here, we present a multiparametric framework combining fractal and multifractal analysis and their distributions to quantify structural alterations in human brain tissue affected by AD. Moreover, from the fractal and multifractal formalism, we introduced an innovative fractal functional distribution method, a novel technique that transforms fractal distribution into a Gaussian form. Statistically, these distribution parameters are easy to interpret and can distinguish between control and diseased tissues. Across samples, we identify pronounced threshold-dependent behavior of fractal and multifractal parameters, reflecting the intrinsic sparsity and heterogeneous intensity landscape of brain tissue. These threshold-sensitive signatures provide a framework for quantitative stage detection and may serve as biomarkers for early pathological transitions. In addition, we studied structural disorder and complexity using our established light localization technique, inverse participation ratio (IPR) analysis. IPR-based analysis demonstrates that increasing IPR pixel size highlights the elevation of structural alterations with disease progression. Together, these integrative analyses establish a robust, multi-scale quantitative framework for detecting microstructural alterations in AD, providing a promising foundation for early diagnosis and improved pathological assessment.

physics.med-ph↗

arXiv2025

Alterations of brain tissue structural complexity and disorder in Parkinson disease (PD): Fractal, multifractal, fractal transformation, and disorder strength analyses

Parkinson disease (PD) is marked by progressive neurodegeneration, yet early and subtle structural alterations in brain tissue remain difficult to detect with conventional imaging and analytical methods. Fractal and multifractal frameworks offer a principled way to quantify complex biological architecture, but their diagnostic utility in PD has been largely unexplored. In this study, we investigated the fractal and multifractal characteristics of human brain tissues to identify structural alterations associated with PD. Alongside conventional fractal and multifractal analysis, we employed a recently developed fractal functional distribution method that transforms distributions into a Gaussian form, thereby enhancing quantification. Using this combined approach, we found notable deviations across multiple distribution metrics in PD samples, offering potential for quantitative staging and diagnostic applications. The multifractal analysis revealed threshold-dependent variations in intensity-based measures, which are linked to the sparsity and heterogeneity of neural tissue and suggestive of potential biomarker value. Additionally, we applied inverse participation ratio (IPR) analysis to assess structural disorder, demonstrating that larger IPR pixel sizes correlate with increased structural complexity during disease progression. These complementary analyses outline a multi-layered quantitative profile of PD-related tissue disruption, offering a foundation for earlier, objective assessment of disease-associated microstructural change.

physics.med-ph↗

arXiv2025

Comprehensive Multimodal and Multiscale Analysis of Alzheimer Disease in 5xFAD Mice: Optical Spectroscopies, TEM, Neuropathological, and Behavioral Investigations

Alzheimer disease (AD) is considered one of the leading causes of death in the United States, and there is no effective cure for it. Understanding the neuropathological mechanisms underlying AD is essential for identifying early, reliable biomarkers and developing effective therapies. In this paper, we report on a comprehensive multimodal study of AD pathology using the 5xFAD mouse model. We employed light-scattering techniques, Partial Wave Spectroscopy (PWS) and Inverse Participation Ratio (IPR), to detect nanoscale structural alterations in brain tissues, nuclear components, and mitochondria. To support the light-scattering experiments, behavior, and histopathological studies were conducted. These analyses revealed significant increases in structural heterogeneity and mass density fluctuations in the brains of 5xFAD mice compared with Non-transgenic controls. Behavioral assessment demonstrated memory impairment in 5xFAD mice, reflected by a reduced recognition index. Histopathological analysis further revealed increased amyloid beta plaques and microglia activation in the hippocampus and cortex of 5xFAD mice compared with Non-transgenic controls. An increase in structural disorder within brain tissues can be attributed to higher mass density fluctuations, likely arising from macromolecular rearrangement driven by amyloid beta aggregation and neuroinflammatory responses as the disease progresses. Our findings suggest that PWS and IPR-derived metrics provide sensitive biophysical indicators of early cellular and subcellular disruption, offering potential as quantitative biomarkers for the detection and progression of AD.

physics.med-ph↗

arXiv2024

Optical detection of the spatial structural alteration in the human brain tissues and cells and DNA and chromatin due to Parkinsons disease

Parkinsons disease (PD) is considered one of the most frequent neurological diseases in the world. There is a need to study the early and efficient biomarkers of Parkinsons, such as changes in structural disorders like DNA and chromatin, especially at the subcellular level in the human brain. We used two techniques, Partial wave spectroscopy (PWS) and Inverse Participation Ratio (IPR), to detect the changes in structural disorder in the human brain tissue samples. It was observed from the PWS experiment that there was an increase in structural disorder in Parkinsons disease tissues and cells when compared to normal tissues and cells using mesoscopic light transport theory. Furthermore, the IPR experiment also showed DNA and chromatin structural alterations that have the same trend and support the PWS results. The increase in mass density in the nuclei components, such as DNA and chromatin, can be linked to the aggregation of alpha-synuclein in the substantia nigra of the brain. This protein deposition is considered a significant cause of neuronal death in the brains of PD patients. We also did a histological analysis of brain tissues, which supports our results from dual photonics techniques. The results show that this dual technique is a powerful approach to detect the changes. Our results highlight the potential of the parameter, related to the structural disorder strength, as an efficient biomarker for PD progress, paving the way for research into early disease detection.

physics.med-ph↗

arXiv2024

Dual Photonics Probing of Nano- to Submicron-Scale Structural Alterations in Human Brain Tissues or Cells and Chromatin or DNA with the Progression of Alzheimers Disease

Understanding alterations in structural disorders in tissue or cells or building blocks, such as DNA or chromatin in the human brain, at the nano to submicron level provides us with efficient biomarkers for Alzheimers detection. Here, we report a dual photonics technique to detect nano- to submicron-scale alterations in brain tissues or cells and DNA or chromatin due to the early to late progression of Alzheimers disease in humans. Using a recently developed mesoscopic light transport technique, fine-focused nano-sensitive partial wave spectroscopy (PWS), we measure the degree of structural disorder in tissues. Furthermore, the chemical-specific inverse participation ratio technique (IPR) was used to measure the DNA or chromatin structural alterations. The results of the PWS and IPR experiments showed a significant increase in the degree of structural disorder at the nano to submicron scale at different stages of AD relative to their controls for both the tissue or cell and DNA cellular levels. The increase in the structural disorder in cells or tissues and DNA or chromatin in the nuclei can be attributed to higher mass density fluctuations in the tissue and DNA or chromatin damage in the nuclei caused by the rearrangements of macromolecules due to the deposition of the amyloid beta protein and damage in DNA or chromatin with the progress of AD.

physics.med-ph↗